Old Web
English
Sign In
Acemap
>
authorDetail
>
Danhua Cong
Danhua Cong
China Pharmaceutical University
Oroxylin A
Translational science
Intensive care medicine
Tocilizumab
Hydroxychloroquine
4
Papers
11
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (4)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Challenges of drug development during the COVID-19 pandemic: key considerations for clinical trial designs.
2020
British Journal of Clinical Pharmacology
Jun Shi
Yubo Xiao
Yiting Zhang
Donghao Geng
Danhua Cong
Kevin X. Shi
Richard J. Knapp
Show All
Source
Cite
Save
Citations (4)
Challenges of drug development during the COVID-19 pandemic: key considerations for clinical trial designs
2020
Jun Shi
Yubo Xiao
Yiting Zhang
Donghao Geng
Danhua Cong
Kevin X. Shi
Richard J. Knapp
Show All
Source
Cite
Save
Citations (0)
Oroxylin A, a methylated metabolite of baicalein, exhibits a stronger inhibitory effect than baicalein on the CYP1B1‐mediated carcinogenic estradiol metabolite formation
2019
Phytotherapy Research
Dongchen An
Zhongjin Song
Yingyue Yi
Qing Zhang
Jinfeng Liu
Yongjie Zhang
Jing Zhou
Guanghui Zhao
Danhua Cong
Ning Li
Yang Lu
Xijing Chen
Di Zhao
Show All
Source
Cite
Save
Citations (2)
Determination of oroxylin A and oroxylin A 7-O-d-glucuronide in HepG2 cell lysate and subcellular fractions with SPE-UPLC–MS/MS: Cellular pharmacokinetic study to indicate anti-cancer mechanisms
2018
Journal of Pharmaceutical and Biomedical Analysis
Qing Zhang
Danhua Cong
Dongchen An
Ali Fan
Qi Liu
Yingyue Yi
Zhongjin Song
Xijing Chen
Yang Lu
Di Zhao
Ling He
Show All
Source
Cite
Save
Citations (5)
1